Most Active Stories
- Dr. Paul Booth, DePaul University – Cultural Meaning of Doctor Who
- Where Did That Fried Chicken Stereotype Come From?
- Dr. Frank Elgar, McGill University – Psychological Health and Family Meals
- NY AG Breaks Cigarette Trafficking Ring, Hints Terror Ties
- Complaints Voiced At Forum About VA Claims Backlog
Shots - Health Blog
Mon March 26, 2012
Study Finds Female Condoms Are Cost-Effective For HIV Prevention
Condoms aren't just for men.
A second generation of female condoms, which was approved in 2009, is cheaper than the first version. Still, the condoms for women are a lot more expensive than those for males. And female condoms remain pretty unfamiliar to most people.
But a new study finds there's no question female condoms are a good bargain when it comes to preventing HIV infections.
Study authors looked at an initiative in Washington, D.C., that distributed 200,000 female condoms to women in neighborhoods with high rates of HIV. The project also educated women (and some couples) on how to use the female condom.
Washington has by far the nation's highest HIV prevalence — 1 in every 33 residents overall. But among those in their 40s, the rate is 1 in 14 residents. That's higher than in many of the most HIV-afflicted countries in Africa.
The project was able to buy female condoms at a cut rate — $1.55 apiece, compared to $2 or more on the retail market. But adding the cost of education sessions, the program spent $3.19 for every female condom that was actually used during sex.
Even so, when the researchers compared the cost of the condom program with the cost of HIV infections it prevented, they find female condoms saved between $15 and $20 for every dollar spent.
Allowing for the fact that some female condoms merely substituted for the use of male condoms (which cost only about 65 cents in a 12-pack), the study finds female condoms are still highly cost-effective — $12.50 to $17 for every dollar spent.
That makes female condoms "a highly productive use of public health investment," conclude David Holtgrave and his colleagues at the Johns Hopkins Bloomberg School of Public Health and Washington's health department.
At least that's the case in areas with high rates of HIV.